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 Dysgenesis of the anterior segment of the eye is a ge-
netically heterogeneous developmental anomaly [1] resulting
in a high risk of glaucoma. One such anomaly is Axenfeld-
Rieger anomaly (ARA), which is occasionally associated with
extraocular alterations such as maxillary hypoplasia, hearing
loss, dental abnormalities, congenital heart defects, redundant
periumbilical skin, and skeletal limb anomalies. ARA patients
with these alterations are said to have “Axenfeld-Rieger syn-
drome” (ARS).
Nishimura et al. [2] identified a patient with primary con-
genital glaucoma who had chromosomal anomalies with a bal-
anced translocation between 6p25 and 13q22. Cloning of the
6p25 breakpoint led to the identification of mutations in the
FOXC1 gene (formerly called FKHL7), and they demonstrated
that mutations in the FOXC1 gene were also detected in pa-
tients with Rieger’s anomaly, Axenfeld’s anomaly, and iris
hypoplasia. These findings demonstrated that mutations in the
FOXC1 gene cause a wide variety of allelic disorders of the
anterior segment such as iridogoniodysgenesis anomaly
(IGDA) associated with glaucoma [3].
In a family with nine affected individuals in three genera-
tions, Mirzayans et al. [4] found that ARS was associated with
a Gln23Stop amino acid substitution in the FOXC1 gene. The
affected individuals presented with different degrees of iris
hypoplasia, displaced pupils (corectopia), and a prominent,
anteriorly-displaced Schwalbe line (posterior embryotoxon).
Peripheral iris strands were seen to bridge the iridocorneal
angle.
Mutations in the FOXC1 gene can cause a wide variety
of phenotypes that share features with Axenfeld anomaly,
Rieger anomaly, ARS, iridogoniodysgenesis anomaly,
iridogoniodysgenesis syndrome, iris hypoplasia,
iridogoniodysgenesis type 1, anterior segment mesenchymal
dysgenesis, and congenital glaucoma [2-13]. Only a small
number of studies have been reported on mutations in the
FOXC1 gene in the Japanese population [11-13]. The purpose
of this study was to determine the ocular and genetic findings
in two Japanese families with ARS.
METHODS
 Genomic DNA was extracted from leukocytes of peripheral
blood and purified by the Qiagen QIAamp Blood Kit (Qiagen,
Valencia, CA). The purpose of the study and the procedures to
be used were explained to all patients and an informed con-
sent was obtained. The procedures used conformed to the te-
nets of the Declaration of Helsinki. This study was approved
by the Tohoku University Institutional Review Board.
The proband in family 1 was a three-year-old girl who
presented at three months of age with early onset severe glau-
coma and who has systemic complications including atrial
septal defect, aortic stenosis, and pulmonary stenosis. Her fa-
ther also manifested early-onset glaucoma. The proband of
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1005the second family was a 38-year-old woman who was diag-
nosed with congenital glaucoma in both eyes at birth. Family
2 had five affected members and at least three affected mem-
bers had similar features. Standard ophthalmic examinations
were performed on all examined patients. Control subjects (52
men and 48 women; mean age 68.0±7.7 years) had IOP>21
mm Hg, normal optic discs, and no family history of glau-
coma.
The forkhead domain (FHD), spanning amino acids 69-
178, was amplified by polymerase chain reaction (PCR) us-
ing 0.5 µM concentration of a pair of primers in an amplifica-
tion mixture (25 µl) containing 0.2 mM dNTPs and 0.5 U of
ExTaq polymerase (Takara, Japan) with 30 ng template DNA.
Oligonucleotide primers used for amplification of FHD of the
FOXC1 gene were forward (sense) primer 5'-AAC TCC CTG
GGA GTG GTG CCC TA-3' and reverse (antisense) primer
5'-CGG CTC CTT GAG GTG CAG CCT-3'. The PCR prod-
ucts were purified using a PCR Purification Kit (PCR Kleen
Spin Columns, Bio-Rad, Hercules, CA) after loading onto a
1.2% agarose gel. Purified fragments were directly sequenced
by the BigDye™ Terminator Cycle Sequencing Ready Reac-
tion Kit (Perkin-Elmer, Foster City, CA) on an automated DNA
sequencer (ABI PRISM™ 3100 Genetic Analyzer, Perkin-
Elmer).
RESULTS
Family 1: Missense Mutation Ala85Pro:  The proband in fam-
ily 1 was a three-year-old girl who presented at three months
of age with hazy megalocornea, posterior embryotoxon, iris
hypoplasia, corectopia with early onset severe glaucoma, atrial
septal defect, aortic stenosis, and pulmonary stenosis. The
horizontal by vertical corneal diameters were 13.0 by 12.5
mm in the right eye (Figure 1) and 12.5 by 11.0 mm in the left
eye. The patient underwent trabeculotomy three times in the
right eye and two times in the left eye. Her father, who had
posterior embryotoxon and iris hypoplasia with early-onset
glaucoma, has been followed by a local ophthalmologist.
We screened the FOXC1 sequence for mutations in this
proband. After direct sequencing, a heterozygous novel point
mutation (G>C) was found at the first nucleotide in codon 85
which changed alanine to proline (Ala85Pro; Figure 2). This
novel missense mutation was identified in two members of
this family, which is consistent with an autosomal dominant
inheritance pattern. The Ala85Pro mutation was not found in
100 ethnically-matched control subjects.
Family 2: Frame-shift mutation 437-453del17:  The
proband of the second family was a 38-year-old woman who
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Figure 1. Right eye of proband 1.  Right eye of proband 1 affected
with ARS, displaying megalocornea, posterior embryotoxon, iris
hypoplasia, and corectopia
Figure 2. Comparison of mu-
tated Ala85Pro with the normal
gene sequence and family 1
pedigree.  At top left, a frag-
ment of the FOXC1 sequence
in an affected subject is shown.
Ala85Pro is shown as a het-
erozygous novel mutation
(G>C) at the first nucleotide in
codon 85 which changed Ala-
nine to Proline, seen at top
right. At bottom left, a frag-
ment of the FOXC1 sequence
in a normal subject is illus-
trated. The pedigree of family
1 is displayed at bottom right.
The solid square indicates the
father and the solid circle indi-
cates the proband.
1006was diagnosed with congenital glaucoma in both eyes at birth.
She underwent trabeculectomy once in the right eye and
trabeculotomy/goniotomy three times in the left eye. The hori-
zontal by vertical corneal diameters were 12.5 by 12.0 mm in
the right eye and 14.5 by 12.0 mm in the left eye. She had
posterior embryotoxon and iris hypoplasia with early-onset
glaucoma (Figure 3). Family 2 had five affected members (Fig-
ure 4) consisting of patients 1, 2, and 3 as the proband, the
father of the proband, and an aunt. All affected members (pa-
tients 1, 2, and 3) had similar features such as hearing loss,
hypertelorism, and telecanthus. A heterozygous novel dele-
tion, 437-453del17, was identified in the coding region of the
FOXC1 gene in two patients in this family (Figure 5). The
mutation segregated with the disease phenotype and the dis-
tribution of the affected members was consistent with an au-
tosomal dominant inheritance pattern. The 437-453del17 mu-
tation was not found in 100 control subjects.
DISCUSSION
 The FOXC1 gene is a member of the forkhead/winged-helix
family of transcription factors. These transcription factors
contain a monomeric, 110 amino acid DNA binding domain,
and forkhead domain (FHD). This motif was originally iden-
tified as a region of homology with the Drosophila
melanogaster forkhead protein [14] and rat hepatocyte nuclear
factor 3 protein (also known as Foxa3) [15]. The FHD is evo-
lutionarily conserved and exists in a wide range of species
from yeasts to humans [16]. This DNA-binding motif is a vari-
ant of the helix-turn-helix motif and consists of three helices
and two large loops that form wing structures, Wing1 and
Wing2 [2,6,17].
Different mutations in the FOXC1 gene have been impli-
cated in the pathogenesis of a wide spectrum of ocular disor-
ders [2-13]. Mutant alleles segregate with the disease pheno-
type. Mutated residues are highly conserved across species
implying that the mutations are probably pathogenic.
The mutations in our patients were found in the α-helix1
in the FHD, which is located at the amino acid position 85 in
family 1 (Figure 6). Previous studies had noted that the NH2-
and COOH-terminal boundaries of the FHD were critical for
proper nuclear localization of FOXA2 and FOXF2 [18,19].
Two lesions are named the nuclear localization signal 1 (NLS1)
and nuclear localization signal 2 (NLS2). The first region,
NLS1, spans residues 77-93 where Ala85Pro is located. Saleem
et al. [8] showed that Leu86Pro disrupts FOXC1 function se-
verely revealing the importance of helix 1 in FOXC1 struc-
ture and function. Thus, there is a possibility that Ala85Pro
reduces the DNA binding and significantly reduces
transactivation.
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Figure 3. Clinical features
of proband in Family 2.
Top: The photo shows the
eyes of proband affected
with ARS. These eyes
display megalocornea,
posterior embryotoxon,
iris hypoplasia, and right
iridectomy (post-
trabeculectomy). Bottom:
Gonioscopic appearance
of patients with proband
illustrates iridocorneal
angle anomaly. This ap-
pearance reveals tissue
strands extending from
peripheral iris to promi-
nent Schwalbe’s line and
a high insertion of iris into
trabecular meshwork.
Figure 4. Pedigree of Family 2.  Solid square indicates the father and
solid circles indicate the proband and women. An arrow points to the
proband. This family had five affected individuals.
1007In family 2, a deletion of 17 nucleotides (437-453) spans
residues 146-151 and is located in Wing1 and Beta2 within
the FHD of the FOXC1 gene. This deletion generates a trun-
cated 298 amino acids FOXC1 protein instead of a 553 full
length amino acid (Figure 6). Therefore, this deletion would
disrupt the nuclear localization signal 2 (NLS2), which con-
tains a basic stretch of amino acids at position
169RRRRRFKK176 at the COOH-terminal end of the FHD. Both
NLSs are necessary for FOXC1 nuclear localization. The first
region, NLS1, may serve as a nuclear localization signal (NLS)
accessory domain and NLS2 could be the true nuclear local-
ization signal [20]. Wing2 was suggested to play an important
role in DNA binding and the transactivation capability of
FOXC1 [9]. So, a deletion of 17 nucleotides (437-453) could
possibly affect the DNA-protein interaction.
A haploinsufficiency of forkhead transcription factors has
been shown to cause aberrant ocular development [2,21]. Con-
sidering these facts, we propose that these mutations may af-
fect the migration and/or differentiation of the mesenchymal
cells that contribute to the anterior segment of the eye [21]
and the developmental processes including embryogenesis and
tissue specific cell differentiation [16,22]. Only a small num-
bers of studies have reported mutations in FOXC1 in the Asian
population [11-13] thus, it is difficult to discuss extensive geno-
type-phenotype correlations. Kawase et al. identified four
mutations: 26-47ins22, Ile91Ser, 286ins1, and Arg127His. The
younger generations had iris hypoplasia with early-onset and
severe glaucoma. The patient with frame-shift mutation, 26-
47ins22, exhibited a more severe phenotype than patients with
the other mutations [11]. Almost all of these mutations are
located in the 110-amino-acid DNA binding domain and FHD,
and are evolutionarily conserved and exist in a wide range of
species from yeasts to humans [16]. All of the FOXC1 muta-
tions could have the net of reducing FOXC1 transactivation
[22]. In our case, frame-shift mutation, 437-453del 17, also
showed high penetrance and slightly more aggressive glau-
coma phenotype. Both frame-shift mutations, 26-47ins22 and
437-453del 17, make truncated proteins and haploinsufficiency
may be correlated with the anterior-chamber defects of the
eye.
Current medical therapies are not successful in decreas-
ing the lower intraocular pressure or in preventing progres-
sion of glaucoma in patients with ARS. Only 18% of patients
with glaucoma and either FOXC1 or PITX2 genetic defects
responded to medical or surgical treatment [23]. The geno-
type-phenotype correlations of the FOXC1 gene may help in
establishing the prognosis of the disease processes and in un-
derstanding the mechanism associated with the various ante-
rior segment dysgenesis caused by the FOXC1 gene.
©2007 Molecular Vision Molecular Vision 2007; 13:1005-9 <http://www.molvis.org/molvis/v13/a108/>
Figure 5. Deleted, normal, and
subcloned gene sequence 437-
453del17 in family 2.  Top: A
fragment of the FOXC1 se-
quence in an affected subject
is revealed to contain a wild
sequence and deletions of 17
nucleotides from 437-453
bases (437-453del17). Middle:
This graph shows a normal
fragment of the FOXC1 se-
quence. Bottom: A subcloned
sequence shows the 437-
453del17.
Figure 6. Summary of the mutations detected in this study.  The
hatched boxes indicate the location of the forkhead domain (FHD)
within the FOXC1 coding sequence. The two white boxes represent
the locations of two polymorphic poly-glycine tract. The distribu-
tion of missense mutation Ala85Pro, and frame shift mutation (437-
453del17) are illustrated. Ala85Pro and 437-453del17 existed in the
FHD. The predicted protein translations are shown below the gene
diagram for the frame shift mutations. The slashed boxes represent
those areas of the protein that are translated differently than the nor-
mal FOXC1 protein; truncated 298 amino acids.
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